Sahil is an Immunologist by training from Weill Cornell and MSKCC. He has published in top tier journals like Science, Nature, and Cell with more than 1000 citations. He has over 4 years of experience of Investing in Biotech including areas like cell therapy, gene therapy, regenerative medicine, oncology, immunology and inflammation, and neurology.